Factors influencing recurrent emergency department visits for mild acute respiratory tract infections caused by the influenza virus.
Acute respiratory infection
Emergency department
Influenza
Recurrent visit
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
06
2023
accepted:
06
09
2023
medline:
12
10
2023
pubmed:
11
10
2023
entrez:
11
10
2023
Statut:
epublish
Résumé
Seasonal viral outbreaks, exemplified by influenza A and B viruses, lead to spikes in emergency department (ED) visits, straining healthcare facilities. Addressing ED overcrowding has become paramount due to its implications for patient care and healthcare operations. Recurrent visits among influenza patients remain an underexplored aspect, necessitating investigation into factors influencing such revisits. Conducted within a tertiary care university hospital, this study adopts an observational retrospective cohort design. The study included adult patients with acute respiratory symptoms diagnosed with influenza using rapid antigen testing. The cohort was divided into single and recurrent ED visitors based on revisits within 10 days of initial discharge. A comparative analysis was performed, evaluating demographics, laboratory parameters, and clinical process data between recurrent visitors and single visitors. Among 218 patients, 36.2% ( This study highlights the pressing concern of recurrent ED visits among mild influenza patients, magnifying the challenges of ED overcrowding. The observed notable prescription rates of antibiotics and antivirals underscore the intricate landscape of influenza management. Diminished monocyte counts, hemoglobin levels, and altered platelet parameters signify potential markers for identifying patients at risk of recurrent visits.
Sections du résumé
Background
Seasonal viral outbreaks, exemplified by influenza A and B viruses, lead to spikes in emergency department (ED) visits, straining healthcare facilities. Addressing ED overcrowding has become paramount due to its implications for patient care and healthcare operations. Recurrent visits among influenza patients remain an underexplored aspect, necessitating investigation into factors influencing such revisits.
Methods
Conducted within a tertiary care university hospital, this study adopts an observational retrospective cohort design. The study included adult patients with acute respiratory symptoms diagnosed with influenza using rapid antigen testing. The cohort was divided into single and recurrent ED visitors based on revisits within 10 days of initial discharge. A comparative analysis was performed, evaluating demographics, laboratory parameters, and clinical process data between recurrent visitors and single visitors.
Results
Among 218 patients, 36.2% (
Conclusion
This study highlights the pressing concern of recurrent ED visits among mild influenza patients, magnifying the challenges of ED overcrowding. The observed notable prescription rates of antibiotics and antivirals underscore the intricate landscape of influenza management. Diminished monocyte counts, hemoglobin levels, and altered platelet parameters signify potential markers for identifying patients at risk of recurrent visits.
Identifiants
pubmed: 37818329
doi: 10.7717/peerj.16198
pii: 16198
pmc: PMC10561640
doi:
Substances chimiques
Anti-Bacterial Agents
0
Hemoglobins
0
Antiviral Agents
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e16198Informations de copyright
©2023 Tatlıparmak et al.
Déclaration de conflit d'intérêts
The authors declare there are no competing interests.
Références
Pediatr Emerg Care. 2021 Dec 1;37(12):e1239-e1243
pubmed: 32058424
Front Immunol. 2014 Dec 18;5:649
pubmed: 25566260
Lancet. 2020 Jan 4;395(10217):42-52
pubmed: 31839279
J Emerg Med. 2016 Mar;50(3):536-42
pubmed: 26763858
Clin Chim Acta. 2018 Jun;481:207-211
pubmed: 29572185
J Infect Dis. 2020 Sep 1;222(7):1235-1244
pubmed: 32369589
Acad Emerg Med. 2017 Sep;24(9):1137-1149
pubmed: 28493626
Clin Infect Dis. 2019 Mar 5;68(6):e1-e47
pubmed: 30566567
Crit Care. 2019 Jun 12;23(1):214
pubmed: 31189475
PLoS One. 2014 Aug 13;9(8):e103761
pubmed: 25118886
BMJ Glob Health. 2020 May;5(5):
pubmed: 32467355
Semin Hematol. 2015 Oct;52(4):261-9
pubmed: 26404438
Vet Microbiol. 2012 Oct 12;159(3-4):499-503
pubmed: 22580193
Int J Mol Sci. 2018 Sep 18;19(9):
pubmed: 30231586
PLoS Curr. 2010 Mar 29;2:RRN1154
pubmed: 20383263
Rev Esp Quimioter. 2021 Sep;34 Suppl 1:63-68
pubmed: 34598431
J Med Virol. 2021 Feb;93(2):1029-1037
pubmed: 32749709
BMC Infect Dis. 2021 Jul 11;21(1):674
pubmed: 34247585
Respir Res. 2009 Jul 12;10:65
pubmed: 19594893
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
Ann Intensive Care. 2017 Dec 1;7(1):115
pubmed: 29192366
Emerg Med Clin North Am. 2020 Aug;38(3):573-587
pubmed: 32616280
Ann Intern Med. 2015 Jun 2;162(11):750-6
pubmed: 26030633
Eur Geriatr Med. 2022 Apr;13(2):339-350
pubmed: 34761369